News NHS must drive forward life sciences strategy, says Lords' l... Big pharma investment "very important", says peer.
News New Teva CEO axes R&D chief Hayden in boardroom shakeup R&D chief Michael Hayden to leave at year end.
News Researchers start trial on AZ WEE1 drug in head and neck can... Phase 1 trial investigates use before and after surgery
News MSD's new research centre a big boost for Brexit Britain But J&J set to snub the UK despite government Life Sciences strategy
Partner Content Partner Content TissUse GmbH to discuss multi-organ-on-a-chip technologies a... SMi reports: Reyk Horland, Vice President, Business Development at TissUse GmbH to discuss “Applying Multi-Organ-on-a-Chip Technologies for Predictive Substance Testing" at SMi’s Drug Discovery con
News Warning over 'handful' of scientists researching new antibio... UK government 'losing focus' on issue since Brexit vote.
Sales & Marketing Biotech is back, with Craig Ackerman In Philadelphia this month, pharmaphorum spoke with Craig Ackerman, a partner at the Alexander Group, about launches, AI best practices, and more.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.
